Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

31 May 2012 07:00

RNS Number : 4649E
Biome Technologies PLC
31 May 2012
 



Biome Technologies plc ("Biome", "the Company" or "the Group")

Trading Update

 

In the trading statement released by Biome on 25 April, it was stated that revenues were slower to achieve than expected in the first quarter, particularly in the Bioplastics Division. Unfortunately, sales within this division have been markedly below our expectation during April and May. The Board now believes that this will have a significant adverse impact on the Group results for the full year; this will be particularly felt in the first half. The RF Division is trading in line with the Board's expectations and its order pipeline remains strong.

 

Customers of the Group's Bioplastics Division are reporting subdued demand for their own bioplastic end products, particularly in the markets of southern Europe. During 2011, the Italian market for bioplastics became one of the largest in Europe following the implementation of regulations (first introduced in early 2011 and reaffirmed in early 2012) mandating the use of biodegradable products for shopping bags. However, in the early part of May this year Biome became aware that the financial penalty for non-compliance with these regulations would now be deferred until the end of 2013. This has resulted in the recent and significant change in the adoption rate in the Italian market and a broader disruption to the supply and demand balance of bioplastics in Europe. In the current, year the Board expects its joint venture company, Biotec, to be the most adversely affected part of the Group.

 

The impact of these changes to the dynamics of the bioplastics' market will result in it taking longer than previously anticipated for the Group to reach profitability. The Group's cash balance as at the end of April was £1.4m. However, this would have reduced significantly as the year progressed unless action is taken to reduce costs. As a result, the Board is taking steps to reduce cash costs by approximately £600k per year. This will better preserve Biome's ability to reach profitability and protect its business model.

 

Whilst the above developments, which affect the fast development of Biome's bio-plastics market, are disappointing, the Board believes firmly that they constitute a pause in a fast-developing market rather than an indication of anything more fundamental.

 

Biome continues to progress successfully with new products and technologies to improve its future prospects and develop new markets. The RF Division is performing well and remains a cash generator for the group as a whole. The Durapipe project remains on track and is successfully passing agreed milestones with our partner. The new technology for heat and cold resistant bio-plastic materials continues to gain positive reaction from product tests with prospective customers. The Board expects these new developments to make contributions to turnover in 2013.

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com Tel: +44 (0) 2380 867 100

 

Daniel Stewart & Company plc

David Hart

www.danielstewart.co.uk Tel: +44 (0) 20 7776 6550

 

First Columbus

Chris Crawford/Kelly Gardiner

www.first-columbus.com Tel: +44 (0) 20 3002 2070

 

FTI Consulting

Oliver Winters/Latika Shah Tel: +44 (0) 20 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKKDPABKDBPN
Date   Source Headline
2nd Jul 20087:00 amRNSTotal Voting Rights
16th Jun 20082:56 pmRNSHolding(s) in Company
16th Jun 20087:00 amRNSHolding(s) in Company
10th Jun 20085:36 pmRNSHolding(s) in Company
4th Jun 20087:00 amRNSAdditional Listing
14th May 20088:53 amRNSDirector/PDMR Shareholding
7th May 20089:51 amRNSDirectors Dealing
7th May 20087:00 amRNSLicense Agreement
1st May 20085:27 pmRNSDirector's Dealings
28th Apr 200811:56 amRNSResult of AGM
28th Apr 20087:00 amRNSAGM and IMS
25th Apr 20083:06 pmRNSDirector/PDMR Shareholding
7th Apr 20084:41 pmRNSSecond Price Monitoring Extn
7th Apr 20084:35 pmRNSPrice Monitoring Extension
7th Apr 20087:00 amRNSAnnual Information Update
2nd Apr 20087:00 amRNSPosting of Annual Report
14th Mar 20087:01 amRNSPreliminary Results
6th Mar 20082:35 pmRNSHolding(s) in Company
3rd Mar 20085:21 pmRNSHolding(s) in Company
29th Feb 20089:43 amRNSSpeculation re plastics
18th Feb 20084:40 pmRNSSecond Price Monitoring Extn
18th Feb 20084:35 pmRNSPrice Monitoring Extension
7th Feb 20084:13 pmRNSNotifiable Interest
4th Feb 200810:25 amRNSHolding(s) in Company
1st Feb 200811:40 amRNSHolding(s) in Company
30th Jan 20084:20 pmRNSNotifiable Interest
30th Jan 20087:01 amRNSNotifiable Interest
28th Jan 200811:22 amRNSNotifiable Interest
21st Jan 20083:27 pmRNSNotifiable Interest
17th Jan 20083:40 pmRNSNotifiable Interest
15th Jan 20084:40 pmRNSSecond Price Monitoring Extn
15th Jan 20084:35 pmRNSPrice Monitoring Extension
15th Jan 20082:28 pmRNSNotifiable Interest
14th Jan 20087:00 amRNSPre Close Update
9th Jan 20084:25 pmRNSHolding(s) in Company
4th Dec 20074:40 pmRNSSecond Price Monitoring Extn
4th Dec 20074:35 pmRNSPrice Monitoring Extension
26th Nov 20074:35 pmRNSPrice Monitoring Extension
25th Sep 20079:54 amRNSNotifiable Interest
10th Sep 20077:02 amRNSInterim Results
28th Aug 20072:33 pmRNSNotifiable Interest
30th Jul 20074:37 pmRNSNotifiable Interest
30th Jul 20074:35 pmRNSNotifiable Interest
27th Jul 20071:56 pmRNSNotifiable Interest
6th Jul 20077:01 amRNSTrading Statement
5th Jul 20076:19 pmRNSDirector Dealings
29th Jun 200712:26 pmRNSTotal Voting Rights
6th Jun 20074:14 pmRNSAdditional Listing
29th May 20075:29 pmRNSDisposal of Assets
29th May 20077:02 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.